-
APPEAL Trial: Landmark International RCT Shows Ciprofloxacin Lowers Post-SWL Infection Risk
Presented by Dr. Kari Tikkinen and team at EAU25, the APPEAL trial is the largest randomized controlled study to date evaluating the role of antimicrobial prophylaxis during shock wave lithotripsy…
-
BOND-003: Intravesical Cretostimogene Shows Durable Responses in High-Risk BCG-Unresponsive NMIBC
Presented by Dr. Trinity Bivalacqua at EAU25, the BOND-003 Phase 3 trial showcases updated data on intravesical cretostimogene grenadenorepvec, an innovative oncolytic immunotherapy for patients with high-risk BCG-unresponsive non–muscle invasive…
-
PROQURE-I: Promising Phase I Data on [¹⁷⁷Lu]Lu-PSMA-617 in Curative Treatment of N1 Prostate Cancer Presented by Dr. Lotte G. Zuur at EAU25
At #EAU25, Dr. Lotte Zuur from the The Netherlands Cancer Institute presented the first results of the PROQURE-I study, a phase I trial evaluating the addition of [¹⁷⁷Lu]Lu-PSMA-617 to standard…
-
“Shared decision-making isn’t just a concept—it’s a measurable determinant of patient satisfaction.”
At hashtag#EAU25, André Deschamps presented the results of the Europa Uomo Patient REported Shared decision making Study (EU-PRESS), shedding light on the link between perceived shared decision-making (SDM) and decision…
-
Dr. Sarah Psutka MD MSc presents interim results from the SunRISe-4 trial at EAU25
At the EAU25 Congress, Dr. Sarah Psutka MD MSc shared promising data from the SunRISe-4 trial evaluating neoadjuvant TAR-200 plus cetrelimab in patients with muscle-invasive bladder cancer (MIBC) who are…
-
EAU25 | Dr. Dr. med. Yannic Volz Presents the PRACTICE Study: Can Prehabilitation Improve Radical Cystectomy Outcomes?
At #EAU25, Dr. Yannic Volz (Ludwig-Maximilians-Universität München) introduced early insights from the ongoing PRACTICE trial (NCT06806059), a randomized, single-blinded study assessing the impact of structured physical activity before radical cystectomy…
-
EAU25 | Sustainability in Uro-Oncology: Comparing the Carbon Footprint of RC vs CRT
At #EAU25, Dr. Vera R. and colleagues from Erasmus MC presented the first study to assess the environmental impact and staff requirements of radical cystectomy (RC) versus chemoradiation (CRT) for…
-
EAU25 | Dr. Seth Lerner Shares First-in-Human Results on Bel-sar (AU-011) in NMIBC
At #EAU25, Dr. Seth Lerner (Baylor College of Medicine) presented early findings from a Phase 1 study (NCT05483868) evaluating Bel-sar (AU-011)—a novel virus-like drug conjugate (VDC) for non-muscle invasive bladder…
Connecting Medical Expertise through Media